GT Biopharma Inc (GTBP)

[trader993]

The Estimated Primary Completion Date of $OXIS cancer drug in
FDA phase 1/2 is June 2017. Good catalyst and not far away.

https://clinicaltrials.gov/ct2/show/study/NCT02370160?term=DT2219ARL&rank=2#contacts

"Estimated Enrollment: 44
Study Start Date: December 2015
Estimated Study Completion Date: June 2018
Estimated Primary Completion Date: June 2017 (Final data collection date for primary outcome measure)"

People should research the cancer drug "DT2219ARL"and "pubmed",many peer review articles.

OXIS seems to be purchasing the licensing rights to 4 mainline drugs with high potential.

Company should find other ways of raising money...but i cannot complain after i bought shares because of it.